Aerinaze (desloratadine;pseudoephedrine)
- Region
- 🇪🇺 EU
- Active substance
- desloratadine;pseudoephedrine
- Company
- Organon N.V.
- Status
- Authorised
- Therapeutic area
- Rhinitis, Allergic, Seasonal
- CHMP opinion
- Thu 24 May 2007
- EU approval
- Mon 30 Jul 2007
- Application
- EMEA/H/C/000772
- ATC
- R01BA52
- Official record
- www.ema.europa.eu
Indication
Symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion.
Regulatory milestones
No milestones recorded in the last year.
Follow Aerinaze
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.